Population-based prevalence surveys during the COVID-19 pandemic: a systematic review
Authors:
- Vinícius Bonetti FranceschiVFVinícius Bonetti Franceschi
- Andressa Schneiders SantosASAndressa Schneiders Santos
- Andressa Barreto GlaeserAGAndressa Barreto Glaeser
- Janini Cristina PaizJPJanini Cristina Paiz
- Gabriel Dickin CaldanaGCGabriel Dickin Caldana
- Carem Luana Machado LessaCLCarem Luana Machado Lessa
- Amanda de Menezes MayerAmanda de Menezes Mayer
- Julia Gonçalves KüchleJKJulia Gonçalves Küchle
- Paulo Ricardo Gazzola ZenPZPaulo Ricardo Gazzola Zen
- Alvaro VigoAVAlvaro Vigo
- Ana Trindade WinckAWAna Trindade Winck
- Liane Nanci RottaLRLiane Nanci Rotta
Preprint
Abstract
Population-based prevalence surveys of COVID-19 contribute to establish the burden and epidemiology of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, their reliability, and biases. The available data described 37 surveys from 19 countries, mostly from Europe and America and using antibody testing. They reached highly heterogeneous sample sizes and prevalence estimates. Disproportional prevalence was observed in minority communities. Important risk of bias was detected in four domains: sample size, data analysis with sufficient coverage, measurements in standard way, and response rate. The correspondence analysis showed few consistent patterns for high risk of bias. Intermediate risk of bias was related to American and European studies, blood samples and prevalence >1%. Low risk of bias was related to Asian studies, RT-PCR tests and prevalence One sentence summary Population-based prevalence surveys of COVID-19 until September 2020 were mostly conducted in Europe and Americas, used antibody testing, and had important risks of bias.Keywords
All Related Versions
- Published version: Reviews in Medical Virology, 31 (4), e2200.
This publication has 57 references indexed in Scilit:
- Seroprevalence of SARS-CoV-2 in Niger State: A Pilot Cross Sectional StudymedRxiv, 2020
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysisBMJ, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessmentsResearch Synthesis Methods, 2020
- Defining the Epidemiology of Covid-19 — Studies NeededNew England Journal of Medicine, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence dataJBI Evidence Implementation, 2015